Up to 20% of patients with OPA1 disease-causing variants develop other systemic symptoms, such as sensorineural hearing loss, progressive external ophthalmoplegia, ataxia, or peripheral neuropathy, which usually follow ocular symptoms are collectively called the ADOA plus syndrome [28,29,30]. This evidence concerns the gene OPA1 and progressive external ophthalmoplegia.